These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 553831)

  • 21. Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives.
    Tani J; Yamada Y; Oine T; Ochiai T; Ishida R; Inoue I
    J Med Chem; 1979 Jan; 22(1):95-9. PubMed ID: 423189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and anticonvulsant activity of 1-(2-(8-(benzyloxy)quinolin-2-yl)-1-butyrylcyclopropyl)-3-substituted urea derivatives.
    He X; Zhong M; Yang J; Wu Z; Xiao Y; Guo H; Hu X
    Chem Biol Drug Des; 2012 May; 79(5):771-9. PubMed ID: 22304806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoquinolines. 3. 3-Aminoisoquinoline derivatives with central nervous system depressant activity.
    Neumeyer JL; Weinhardt KK; Carrano RA; McCurdy DH
    J Med Chem; 1973 Jul; 16(7):808-13. PubMed ID: 4725927
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis of D,L beta-aminomethyl derivatives of gamma-(p-chlorophenyl)-tetrahydrofuran-2-one.
    Jakóbiec T; Zabska R; Zawisza T
    Pol J Pharmacol Pharm; 1982; 34(4):247-55. PubMed ID: 6820691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anticonvulsant activity of some 2-(2-{1-[substituted phenyl]ethylidene}hydrazinyl)-4-(4-methoxy-phenyl)-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile.
    Shaquiquzzaman M; Khan SA; Amir M; Alam MM
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):825-31. PubMed ID: 21981001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of p-chlorophenylalanine on the central nervous excitability threshold and on the activity of some central depressants.
    Georgiev VP; Petkova BP
    Med Biol; 1975 Feb; 53(1):47-50. PubMed ID: 124805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system depressant effects of N3-substituted derivatives of deoxyuridine in mice.
    Kimura T; Kuze J; Teraoka S; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Biol Pharm Bull; 1996 Jan; 19(1):142-5. PubMed ID: 8820928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant effects of certain CNS depressants in convulsions induced by strychnine, metrazol or caffeine.
    CHEN G; ENSOR CR; PORTMAN R
    Arch Int Pharmacodyn Ther; 1956 Jan; 104(3-4):333-8. PubMed ID: 13314702
    [No Abstract]   [Full Text] [Related]  

  • 29. (1,3-Dialkyl-5-amino-1H-pyrazol-4-yl)arylmethanones. A series of novel central nervous system depressants.
    Butler DE; Wise LD; DeWald HA
    J Med Chem; 1984 Nov; 27(11):1396-400. PubMed ID: 6492070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sydnone derivatives. Part VII: Synthesis of some novel thiazoles and their pharmacological properties.
    Kalluraya B; Rahiman AM; Banji D
    Arch Pharm (Weinheim); 2001 Sep; 334(8-9):263-8. PubMed ID: 11688135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some aspects of the neuropharmacology of phenylurea.
    Zirvi KA; Fakouhi T
    Arzneimittelforschung; 1977; 27(6):1194-8. PubMed ID: 578440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant properties of some new derivatives of phensuccinimide.
    Rump S; Ilczuk I; Walczyna K
    Arzneimittelforschung; 1979; 29(2):290-2. PubMed ID: 582142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives.
    Tatsuta M; Kataoka M; Yasoshima K; Sakakibara S; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta J; Urbahns K
    Bioorg Med Chem Lett; 2005 May; 15(9):2265-9. PubMed ID: 15837306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant activity of ectylurea in mice.
    Ljungberg S; Paalzow L; Ström S
    Acta Pharm Suec; 1968 Sep; 5(4):293-8. PubMed ID: 5724372
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclopentenyl ethylamines active on CNS.
    Mulè A; Pirisino G; Moretti MD; Sparatore F; Dimich PM; Satta M; Peana A
    Farmaco; 1992 Sep; 47(9):1161-72. PubMed ID: 1300121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Synthesis of Novel Phenylpiperazine Derivatives as Potential Anticonvulsant Agents.
    Habib MM; Abdelfattah MA; Abadi AH
    Arch Pharm (Weinheim); 2015 Dec; 348(12):868-74. PubMed ID: 26457479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants.
    Lien EJ; Liao RC; Shinouda HG
    J Pharm Sci; 1979 Apr; 68(4):463-5. PubMed ID: 438970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS activities of ethanol extract of aerial parts of Hygrophila difformis in mice.
    Pal D; Samanta K
    Acta Pol Pharm; 2011; 68(1):75-81. PubMed ID: 21485704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsant activity of N,N'-bis[3-(3-substituted urea)propyl]piperazines.
    Chaturvedi AK; Barthwal JP; Parmar SS; Stenberg VI
    J Pharm Sci; 1975 Mar; 64(3):454-6. PubMed ID: 1151634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.